“…Finally, 27 case-control studies with 7856 ovarian and cervical cancer cases and 11,263 controls were included. Among these studies, eleven case-control studies with 4990 cases 7730 controls were on ovarian cancer (Jakubowska et al, 2007;Wu et al, 2007;Terry et al, 2010;Prasad and Wilkhoo, 2011;Webb et al, 2011;Gao et al, 2012;Pawlik et al, 2012;Zhang et al, 2012;Özkılıç et al, 2016) and 16 case-control studies with 2,866 cases 3,533 controls were on cervical cancer (Lambropoulos et al, 2003;Sull et al, 2004;Zoodsma et al, 2005;Kang et al, 2005;Delgado-Enciso et al, 2006;Ma et al, 2006;Shekari et al, 2008;Nandan et al, 2008;Kohaar et al, 2010;Tong et al, 2011;von Keyserling et al, 2011;Yang et al, 2011;Mostowska et al, 2011; Figure 1. The Flow Diagram of the Included and Excluded Studies = 0.202), and recessive (TT vs. TC+CC: OR = 1.110, 95% CI 0.876-1.406, p = 0.389).…”